As in animals, plants have immune responses that help them defend against pathogens such as viruses, bacteria, fungi, and oomycetes. Before invaders can be stopped, they must first be detected, and this is accomplished by pattern recognition receptors located on the surface of plant cells
Much of our understanding of viral respiratory illnesses such as COVID-19 and influenza is based on investigations of symptomatic patients. A new longitudinal study of symptomatic, asymptomatic, and mild illnesses conducted by Columbia University researchers gives information on how our bodi
Experts believe China will continue to experience various respiratory pathogens alternating or co-circulating in the winter and the coming spring, with influenza viruses still dominating in the short term.
Understanding how viruses spread once they enter the human body is crucial for developing medications and therapies that can stop viruses in their tracks.
Researchers discovered a previously unknown class of antibodies--immune system proteins that guard against disease--that appear to be capable of neutralising different strains of flu virus.
The event will bring together over 100 participants, including representatives from the Global disease prevention and diagnostic laboratories in 60 countries and international experts.
Amid rising cases of respiratory illness in China, Dr SK Kabra, (HoD Mother and Child Block, All India Institute of Medical Sciences, AIIMS) has said that viral infections are common in winters and there is no possibility of another pandemic like COVID yet.
A vaccine developed by Duke Human Vaccine Institute researchers that protects against three distinct fatal coronaviruses has shown success in animal studies, indicating the potential for pan-coronavirus immunisation.
A vaccine created by researchers at the Duke Human Vaccine Institute that protects against three separate lethal coronaviruses has shown success in mouse trials, suggesting the potential of a pan-coronavirus vaccination.
Earlier it was reported, at least one person in every family is expected to be suffering from Hepatitis B and C viruses in Pakistan and requires relevant measures to overcome the disease.
Researchers from the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health have made an important discovery about Aedes aegypti mosquitos, which could one day lead to better methods for reducing mosquito-to-human transmission of dengue, yellow fever,
According to recent research published in the Journal of Experimental Medicine, equipping cancer-infecting viruses with tumor-inhibiting genetic cargo boosts the immune system and supports immunotherapy in reducing or totally eradicating aggressive tumours in mice. The findings pave the path